Scollay Named RMTC Executive Director

POSTED ON  |  06-07-2019

Mary Scollay
Dr. Mary Scollay has been named executive director and chief operating officer of the Racing Medication and Testing Consortium (RMTC), effective Aug. 5. Scollay will be charged with the advancement of drug testing standards, promotion of RMTC-recommended rules and penalties for prohibited substances and therapeutic medications, monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, and administrative oversight of RMTC-funded research projects and educational programs.

“We are very pleased to have Dr. Scollay on board,” said RMTC chair Alex Waldrop. “She has been working with the RMTC for years now, and that will enable her to hit the ground running in this new capacity, at a pivotal time for the RMTC and the entire horse racing industry.”

Scollay most recently held the position of equine medical director for the Kentucky Horse Racing Commission and adjunct faculty member at the University of Kentucky. Prior to that,  Scollay spent numerous years as the Senior Association Veterinarian for Calder Race Course and Gulfstream Park, as well as an adjunct faculty member for Miami Dade College’s Department of Veterinary Technology.

Scollay has represented the Kentucky Equine Drug Research Council on the RMTC board of directors and Scientific Advisory Committee (SAC) since 2013. She also participated on the Horseracing Testing Laboratories Committee and chaired the SAC Communications Committee, where she assisted in the development of educational materials on test barn chain of custody and procedures, responsibly managing your horse’s environment, the 95/95 tolerance interval, and threshold and withdrawal guidelines for controlled therapeutic substances.

© 2015 IGSRV All rights reserved.